22 Feb 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
19 Jul 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/07/19/2481807/0/en/SCYNEXIS-Presents-Positive-Data-from-Phase-3-CANDLE-Nested-Sub-Study-Investigating-Ibrexafungerp-in-Women-with-Recurrent-Yeast-Infections-Who-Failed-Fluconazole-During-the-ISSVD-XX.html
04 Oct 2021
// FIRSTWORDPHARMA
https://www.healio.com/news/womens-health-ob-gyn/20211001/oteseconazole-proves-safe-effective-against-recurrent-vulvovaginal-candidiasis
12 Aug 2021
// BUSINESSWIRE
06 Jul 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-acquisition-of-fluconazole-tablets-301088173.html#:~:text=ANI%20Pharmaceuticals%2C%20Inc.&text=(%22ANI%22)%20(Nasdaq,according%20to%20IQVIA%2FIMS%20Health.
16 Oct 2018
// ANVISA
http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/anvisa-aprova-vacina-influenza-para-idosos/219201?p_p_auth=kATyHONb&inheritRedirect=false&redirect=http%3A%2F%2Fportal.anvisa.gov.br%2Fnoticias%3Fp_p_auth%3DkATyHONb%26p_p_id%3D101_INSTANCE_FXrpx9qY7FbU%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3D_118_INSTANCE_veHKmkDUo2dN__column-2%26p_p_col_count%3D2